Bennet W M, Haymond M W
Endocrine Research Unit, Mayo Clinic and Foundation, Rochester, Minnesota 55905.
Am J Physiol. 1991 Apr;260(4 Pt 1):E581-7. doi: 10.1152/ajpendo.1991.260.4.E581.
To assess the contributions of leucine and alpha-ketoisocaproate (KIC) derived from the portal vein vs. hepatic artery for hepatic protein synthesis, 14-postabsorptive dogs were infused simultaneously with [1-14C]- and [4,5-3H]leucine or [1-14C]- and [4,5-3H]KIC. On one occasion one tracer was infused via a leg vein and the other via mesenteric infusion catheters, and dogs were restudied with both tracers infused systemically. The ratios of systemically to portally infused tracers in portal and arterial plasma leucine were used as indexes of the radioactivity in the potential precursor pools and in fibrinogen-bound leucine as a paradigm of hepatic protein synthesis. In the dogs given leucine tracers, the relative proportions of systemically to portally infused radioactivity in portal free leucine (0.50 +/- 0.06) were lower (P less than 0.001) than in arterial free leucine (1.22 +/- 0.03) and not different from that bound in fibrinogen (0.43 +/- 0.02). In the dogs infused intraportally with KIC, these values were 0.81 +/- 0.04, 0.97 +/- 0.05, and 0.74 +/- 0.05, respectively. In the control studies these ratios were not significantly different from the expected value of 1.0. The results suggest that, in postabsorptive dogs, fibrinogen is exclusively synthesized from portally delivered leucine with little or no contribution from the hepatic artery, whereas portally delivered KIC contributes little directly to fibrinogen synthesis. These data are consistent with zonation of hepatic amino acid metabolism and/or protein synthesis.
为评估门静脉与肝动脉来源的亮氨酸和α-酮异己酸(KIC)对肝脏蛋白质合成的贡献,对14只禁食后的犬同时输注[1-¹⁴C]-亮氨酸和[4,5-³H] -亮氨酸或[1-¹⁴C]-KIC和[4,5-³H] -KIC。一次实验中,一种示踪剂经腿部静脉输注,另一种经肠系膜输注导管输注,然后对犬进行两种示踪剂全身输注的再研究。门静脉和动脉血浆亮氨酸中全身输注与门静脉输注示踪剂的比率,用作潜在前体库中放射性的指标,以纤维蛋白原结合的亮氨酸作为肝脏蛋白质合成的范例。在给予亮氨酸示踪剂的犬中,门静脉游离亮氨酸中全身输注与门静脉输注放射性的相对比例(0.50±0.06)低于动脉游离亮氨酸中的比例(1.22±0.03,P<0.001),且与纤维蛋白原中结合的比例无差异(0.43±0.02)。在门静脉内输注KIC的犬中,这些值分别为0.81±0.04、0.97±0.05和0.74±0.05。在对照研究中,这些比率与预期值1.0无显著差异。结果表明,在禁食后的犬中,纤维蛋白原仅由门静脉输送的亮氨酸合成,肝动脉贡献很少或没有贡献,而门静脉输送的KIC对纤维蛋白原合成的直接贡献很小。这些数据与肝脏氨基酸代谢和/或蛋白质合成的区域化一致。